人 民 网 版 权 所 有 ，未 经 书 面 授 权 禁 止 使 用
2024年12月24日 星期二 新京报
，更多细节参见搜狗输入法2026
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
Could weight-loss jabs be behind rising gallbladder removals?